<DOC>
	<DOCNO>NCT00255580</DOCNO>
	<brief_summary>The purpose study determine medicinal cannabis ( marijuana ) safe effective treating pain individual HIV-associated distal , sensory-predominant polyneuropathy ( DSPN ) .</brief_summary>
	<brief_title>Medicinal Cannabis Painful HIV Neuropathy</brief_title>
	<detailed_description>Peripheral neuropathy occur 30 % patient HIV infection , make among common neurological complication HIV infection . Nucleoside analogues ddI d4T , key component modern , potent , combination antiretroviral therapy ( ART ) , also neurotoxic contribute frequent occurence painful neuropathy . By use treatment available non-narcotic analgesic adjunctive pain medication , approximately half patient painful HIV neuropathy obtain sufficient pain control . On first day study week ( active placebo ) , participant follow specific titration procedure achieve optimal dose . This optimal dose continue duration treatment week . Participants undergo 2-week washout period , crossover arm ( active placebo ) repeat dose titration dose maintenance procedure . Comparison : Active cannabis dos range 2-8 % THC compare placebo reduction neuropathic pain .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Documented HIV infection Meets clinical electrodiagnostic criterion HIVassociated DSPN entry Daily pain least three consecutive month average daily pain magnitude score least 5 Descriptor Differential Scale Inadequate pain relief prior treatment painful HIV neuropathy use drug least two different class painmodifying agent ( NSAIDS , lowpotency opioids , highpotency opioids , sodium channel blocker , adjunctive pain treatment ) Age 2165 year Stable use opioid nonopioid analgesic medication two week prior study entry Positive urine toxicology screen cannabinoids `` washin '' week prior initiate study treatment Recent ( i.e . month prior study entry ) history marijuana use twice week Previous psychosis intolerance cannabinoids A lifetime history ( ever ) dependence cannabis Meeting criterion alcohol drug dependence within last 12 month Active , major psychiatric disorder likely , investigator 's opinion , interfere adherence study protocol Active AIDSdefining opportunistic disease ( history AIDSdefining opportunistic disease longer active progress ground exclusion ) Diabetes mellitus , renal failure uremia , alcohol abuse , previous spinal surgery , document cause neuropathy neuropathic pain Pulmonary disease sufficient severity require use supplemental oxygen Asthma Life expectancy le 6 week active , acute illness likely interfere completion study protocol Pregnancy Failure use adequate birth control individual reproductive potential Minority status ( less 21 year ) , person age 65 year</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>neuropathy</keyword>
	<keyword>cannabis</keyword>
	<keyword>marijuana</keyword>
	<keyword>HIV</keyword>
	<keyword>DSPN</keyword>
</DOC>